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Background: Understanding the molecular features of bone
repair and osseointegration may aid in the development of
therapeutics to improve implant outcomes. The purpose of this
investigation is to determine the gene expression dynamics
during alveolar bone repair and implant osseointegration.
Methods: An implant osseointegration preclinical animal
model was used whereby maxillary defects were created at
the time of oral implant placement, while a tooth extraction
socket healing model was established on the contralateral
side of each animal. The surrounding tissues in the zone of
the healing defects were harvested during regeneration for
temporal evaluation using histology, immunohistochemistry,
laser capture microdissection, and quantitative reverse tran-
scription–polymerase chain reaction for the identification of
a panel of 17 putative genes associated with wound repair.
Results: In both models, three distinct expression patterns
were displayed: 1) genes that are slowly increased during
the healing process, such as bone morphogenetic protein 4,
runt-related transcription factor 2, and osteocalcin; 2) genes
that are upregulated at the early stage of healing and then
downregulated at later stages, such as interleukin and
chemokine (C-X-C motif) ligands 2 and 5; and 3) genes that
are constitutively expressed over time, such as scleraxis.
Although some similarities between osseointegration and
tooth extraction socket were seen, distinct features devel-
oped and triggered a characteristic coordinated expression
and orchestration of transcription factors, growth factors, ex-
tracellular matrix molecules, and chemokines.
Conclusions: Characterization of these events contributes
to a better understanding of cooperative molecular dynamics
in alveolar bone healing, and highlights potential pathways
that could be further explored for the enhancement of osseous
regenerative strategies. J Periodontol 2011;82:1007-1017.
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U
nderstanding important features
of alveolar bone development,
maturation, and repair has pro-
vided a wealth of information, lending
insight toward promising therapeutic
approaches that can bolster endogenous
osseous regeneration in response to in-
jury.1-4 Currently, therapeutic approaches
to enhance bone regenerative potential
are available and continue to be opti-
mized.3,5-7 Identifying and understanding
the dynamics of these important osteo-
genic environmental cues within alveolar
socket healing and the osseointegration
process are of critical importance. Greater
knowledge about factors expressed dur-
ing bone repair could serve as a foun-
dation for novel therapeutic alternatives,
addressing clinically challenging situa-
tions that often compromise the proper
restoration of the bone’s function and
structure.8
The processes of alveolar tooth extrac-
tion socket healing and bone–implant
osseointegration are similar in terms of
bone healing, including such events as
early protein expression, cell apposition,
remodeling, and maturation of the healing
site. At the microscopic level, the bone
healing process starts with the formation
of a coagulum, followed by infiltration of
inflammatory cells that initiate removal
of necrotic tissue. Subsequently, loose
connective tissue migrates in and helps
stabilize the extracellular matrix. This re-
parative fibrous connective tissue is even-
tually replaced by newly formed woven
bone, and ultimately by lamellar bone
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and bone marrow.9,10 At the molecular level, initial
hematoma formation results in the release of platelet-
derived growth factor, insulin-like growth factors, tumor-
derived growth factor b, and fibroblast growth factors.
These growth factors act as mitogenic and angiogenic
signals at the early stage of bone healing. With the in-
filtration of connective tissue, the expression of bone
morphogenetic proteins (BMPs) increases and os-
teogenesis is initiated.11 Although extraction socket
healing and osseointegration share many common
aspects, they still have some differences: because
of the trauma during osteotomy, the inflammatory re-
sponse in osseointegration seems stronger than in the
extraction socket healing site; and periodontal liga-
ment (PDL) remnants may play a role in extraction
socket healing, but PDL cells are not involved in os-
seointegration.
The biology of alveolar socket healing and implant
osseointegration has been an area of intense re-
search. However, because it is difficult to dissect the
socket healing area from the alveolar bone for gene
expression assay, most previous studies focus on his-
tologic aspects of the healing process.12-18 Very few
investigations try to understand the dynamic gene ex-
pression profiles with emphasis on the spatial and
temporal molecular characteristics.19-22 Regarding
osseointegration, although the gene expression pro-
file of bone–titanium integration in long bone has been
investigated by different methods, such as reverse
transcription-polymerase chain reaction (RT-PCR)
and microarray,17,23 there is a scarcity of data regard-
ing osseointegration dynamics in the oral cavity.
The purpose of this study is to determine the gene
expression dynamics during alveolar bone healing
and osseointegration. We used laser capture micro-
dissection (LCM) to clearly dissect the tooth extraction
healing region and implant osseointegration sites from
alveolar ridge defects and identify gene expression
profiles in a temporal fashion. The expression of a
group of genes associated with osteogenesis, including
growth factors, transcription factors, and chemokines,
was examined and the results of selected gene markers
were compared to bone reparative responses histolog-
ically. The knowledge obtained from this study should
shed light on the design of future therapies for alveolar
bone healing and osseointegration.
MATERIALS AND METHODS
Experimental Design
Ethical board approval was obtained for this preclin-
ical investigation by the University of Michigan, Unit
for Laboratory Animal Medicine, Ann Arbor, Michigan.
A total of 24 male Sprague–Dawley rats, 4 weeks of
age, were used in this study.§ The experimental time-
line is shown in Figure 1. Animals were anesthetized
under general anesthesia using ketamine (50 mg/
kg) and xylazine (10 mg/kg) for the extractions and
implant placements. Briefly, the first molars (M1) on
one side of each maxilla were extracted. After 1
month, an osteotomy was performed at the residual
ridge defects, and implants were placed as previously
described.24 Concurrent with implant placement, M1
teeth on the contralateral side of the maxillae were
extracted. In previous studies, 60% bone defect fill
and 35% bone–implant contact were seen 14 days af-
ter implant placement.24,25 To determine the gene ex-
pression profiles at early and late stages of healing,
but prevent significant tissue damage while removing
the implants, day 14 was selected as an endpoint. The
animals were euthanized and the maxillae were dis-
sected at 3, 7, 10, and 14 days after implant place-
ment or tooth extraction. At each time point,
Histologic evaluation including hematoxylin and eo-
sin staining for tooth extraction and implant defect
sites was performed on samples from six animals, fol-
lowed by LCM, RNA extraction, and quantitative RT-
PCR. Subsequently, immunohistochemistry staining
was performed for selected genes (Postn and Runx2)
to confirm the gene expression profiles.
Tooth Extraction, Defect Creation, Implant
Placement
The surgical procedure is shown in Figure 1. Tooth ex-
traction was performed by ZL, QJ, and HFR, and the
implant placement was done by ZL and QJ. Briefly,
the maxillary first molars (M1) were extracted using
an atraumatic technique. The extraction sockets and
soft tissues were allowed to heal for 30 days. After
healing, an osteotomy was created using a custom
drill as previously described.24 The drill-bit was de-
signed with a 0.95-mm diameter, 1-mm long apical
portion and a 2.2-mm diameter, 1-mm long at the cor-
onal aspect. The apical part of the drill created an os-
teotomy for initial fixation and the coronal part of the
drill created a circumferential osseous defect before
dental implant placement. The implants consisted
of custom-fabricated, sterile, commercially pure, solid-
cylinder titanium implants with a chemically modi-
fied surface by extensive hydroxylation/hydration
with an average 4.1 to 4.7 mm roughness designed
to the appropriate dimensions for placement into
the rat maxillae (2 mm in length and 1 mm in diame-
ter).i The implants were press fit into position and
evaluated for primary stability. The surgical field
was closed by means of tissue glue.¶ The animals
were observed postoperatively on a heating pad until
fully alert to ascertain their response to surgery. To
maintain energy and prevent infection, animals were
§ Charles River Laboratories, Wilmington, MA.
i Institute Straumann AG, Waldenburg, Switzerland.
¶ PeriAcryl, n-butyl cyanoacrylate, GluStitch, British Columbia.
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given a 10% dextrose solution containing 268 g/L
ampicillin for 1 week post-surgery. A normal diet
was continued for the animals.
Laser Capture Microdissection
The animals were sacrificed by CO2 euthanasia at the
designated time points after surgery. Block biopsies
were harvested and immediately fixed with 10% phos-
phate-buffered neutral formalin for 24 hours. Biopsies
were decalcified for 14 days in 10% EDTA solution.
After implants were gently removed, biopsies were
embedded in paraffin and cut sagittally along the axis
of the tooth into 7-mm sections by microtome. LCM
was performed to dissect out the areas of interest
(see supplementary Fig. 1 in online Journal of Peri-
odontology). Two different tissues from each animal
were collected: osteotomy defect area and tooth ex-
traction healing site. Demineralized tissue samples
embedded in paraffin blocks were submitted to the
University of Michigan Histology Core for sectioning.
A total of three slides# containing three sections were
cut for each sample block. The non-stained slides
were then deparafinized by washing with xylene, two
washes of 10 minutes per wash. The slides were air-
dried. An LCM microscope** was used to cut the entire
healing tooth extraction socket and peri-implant defect
tissue. The tissues were collected into microcentrifuge
tubes that contained RLT lysis buffer.†† RNA was iso-
lated using a kit.‡‡
Quantitative RT-PCR
Total RNA samples were extracted with a kit§§ accord-
ing to the manufacturer’s instructions. RNA was sub-
jected to RT in a 50-mL RT reaction using TaqMan
RT reagents.ii cDNA was generated using random
Figure 1.
Alveolar socket and peri-implant defect healing study models and timeline. The top and bottom panels represent the sequence of events that
characterize the extraction and peri-implant healing models, respectively. The left first maxillary molar (M1) was extracted and allowed to completely
heal for 28 days. On the healed ridge, an implant osteotomy was created that allowed implant placement and creation of a standardized peri-implant
defect. In the contralateral side, M1 was extracted. LCM and histology (HISTO) methods were used for the analysis and evaluation of the
healing area (black dotted line) at days 3, 7, 10, and 14.
# Slides for Laser Microdissection, Leica Microsystems, Bannockburn, IL.
** LMD 7000, Leica Microsystems.
†† RNeasy Micro Kit, Qiagen, Valencia, CA.
‡‡ RNeasy Micro Kit, Qiagen.
§§ RNAeasy Kit, Qiagen Sciences, Germantown, MD.
ii Applied Biosystems, Foster City, CA.
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hexamer primers and oligo-T primers with 2:1 ratio.
Subsequently, a preamplification kit was used to
boost the low cDNA amount from LCM dissection.¶¶
For quantitative real-time PCR, the generated cDNA
was analyzed, in triplicate, with a mix## in a sequence
detection system.*** The results were normalized
with the 18S transcript. Primers and probes for Bmp7,
wingless-type MMTV integration site family, member
(Wnt) 4, 5A, 10b, CXCL5, transforming growth factor
(Tgf)-b1, Bmp4, vascular endothelial growth factor
(Vegf), interleukin (Il)-1b, Cxcl2, periostin (Postn),
osteopontin (Opn), osteocalcin (Ocn), RUNX2, Lim
domain mineralization protein (Lmp1), scleraxis
(Scx), and Cxcl12/Sdf1 were ordered from a man-
ufacturer.†††
Immunohistochemistry
The specimens were dissected and fixed in 10% neu-
tral buffered formalin at 4C for 24 hours; demineral-
ized in 10% EDTA solution over 3 weeks; dehydrated;
embedded in paraffin; and processed for section-
ing (6-mm thickness). Immunostaining of POSTN
(ab14041, affinity purified rabbit polyclonal anti-
body)‡‡‡ and RUNX2 (ab54868, mouse mono-
clonal)§§§ was performed on paraffin sections using
1:8,000 and 1:1,000 primary antibody dilutions, re-
spectively. Immunologic reactions were visualized by
using an anti-rabbit HRP/DAB detection kit method
(ab64261).iii Bovine serum albumin 1% was used
as a negative control. Sections were counterstained
with hematoxylin and mounted on glass slides for
analysis.
Statistical Analysis
Statistical analysis was performed using a software
program.¶¶¶ All data are presented as the mean –
SEM. The two-tailed analysis of variance statistical
test was used to determine whether the differences
in expression among groups were statistically signif-
icant at different time points. Bonferroni post hoc
analysis of statistical significance was used to identify
these differences. P values <0.05 were considered
statistically significant.
RESULTS
Descriptive Histology of Tooth Extraction Socket
During Healing
Histologically, the extraction sockets followed a well-
defined healing sequence (Fig. 2). At 3 days, large
clots were seen in the sockets, surrounded by scat-
tered neutrophils and a large amount of mesenchymal
cells (severed PDL). At 7 days, the coagulum area
condensed to a relatively small size, and more fibro-
blasts appeared in sockets. Newly formed bone,
which is less stained, could be easily seen. At 10 days,
clots were replaced by fibroblasts and new bone. At
14 days, the sockets were completely filled by new
bone and bone marrow.
Descriptive Histology of Bone Healing and
Osseointegration Around Dental Implants
Histologically, the healing after osteotomy was similar
to extraction socket healing (Fig. 3). However, the
healing appeared delayed with greater infiltration by
inflammatory cells as seen in early stages. At the early
stage (3 days), some blood clots were seen in the de-
fect area. Few cells were found, and most of them were
immune cells and scattered epithelial cells. By 7 days,
the cell density in the defect area was higher and more
extracellular matrix was seen. At 10 days, the defect
site was mainly filled by fibroblasts. The border of the
osteotomy site became less well defined, and newly
formed bone started to grow into the defect area. At
14 days, more defect area was replaced by newly
formed bone. Osseointegration could be observed
during this stage.
Gene Expression Pattern of Tooth Extraction
Socket Healing
We performed LCM to analyze the expression profile
of genes associated with wound healing. We tested
17 genes, which can be categorized into three differ-
ent groups: 1) growth factors and chemokines, 2)
extracellular matrix proteins, and 3) transcription fac-
tors. Three expression patterns were evident (Fig. 4).
The first pattern was genes that were slowly increased
during the healing process: growth factors (Bmp4,
Bmp7, Wnt10b, and Vegf ), transcription factors
(Runx2), and extracellular matrix proteins related to
mineralized tissue (Opn and Ocn) were in this
group. Very interestingly, Cxcl12 (Sdf1) gradually in-
creases during extraction socket healing. Tgf-b1 in-
creases at a mid-stage of healing (day 10) and then
decreases. Similarly Postn, a target gene of Tgf-b1,
had the same expression pattern. The second pattern
was genes that were highly expressed at early time
points and were downregulated at later stages. Che-
mokines Il-1b, Cxcl2, and Cxcl5 belonged to this cat-
egory, although we did not see a statistical difference
because of the limited number of animals. Wnt5a and
Wnt4 also seemed to decrease during healing. The
final pattern was genes that were constitutively
expressed. Lmp1, a scaffold protein that is involved
in osteogenesis, and tendon-specific transcriptional
factor Scx were in this group.
¶¶ Applied Biosystems.
## Master Mix, Applied Biosystems.
*** ABI7500 Sequence Detection System, Applied Biosystems.
††† Applied Biosystems.
‡‡‡ Abcam, Cambridge, MA.
§§§ Abcam.
iii Abcam.
¶¶¶ GraphPad Prism, GraphPad Software, La Jolla, CA.
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Gene Expression Pattern During Bone
Regeneration Around Implants
The same 17 genes were also analyzed (Fig. 5). Inter-
estingly, we were unable to detect some of the genes
from osteotomy samples, such as Bmp7, Wnt4,
Wnt5a, Wnt10b, and Cxcl5. The remaining genes fol-
lowed a similar pattern as of extraction socket heal-
ing. Consistent with histologic images, at the early
inflammation stage chemokines, such as IL-1b and
Cxcl2, were highly expressed in the defect area and
decreased at late time points. During healing, the ex-
pression of osteogenesis-related growth factors and
chemokines (e.g., Bmp4, Tgf-b1, and Cxcl12/Sdf1)
was gradually increased over time. Transcription fac-
tor Runx2 followed the same trends. The expression
of extracellular matrix proteins including Opn and
Postn significantly increased at later stages (days
10 and 14). Interestingly, Lmp1 gene expression
was relatively high at day 3, but steadily decreased
at later stages.
POSTN Protein Localization During Tooth
Extraction Socket Healing
POSTN distribution within the healing socket clearly
depicts areas of residual PDL structures around the
wall of the alveolus at 3 days (Fig. 2). However, the
proliferative granulation tissue that characterizes
this healing stage presents minimal to no POSTN
signal. By day 7, the sockets presented a denser
connective tissue and a significant area was occupied
by woven bone. The fibrous connective tissue present
at this time point corresponded to an increased
POSTN signal intensity. The POSTN distribution and
localization among non-mineralized areas seems
more homogeneous and intense by 10 days, but it
seems to be present only within the less mature areas.
This pattern seems to continue and by 14 days most
of the socket is filled with mature trabecular bone, and
therefore the POSTN signal is more localized and
highlights isolated areas of greater bone metabolic
activity.
Figure 2.
Histologic evaluation of alveolar socket healing sites over time. Hematoxylin and eosin (H&E), RUNX2, and POSTN immunohistochemistry for tooth
extraction site healing at 3, 7, 10, and 14days (left panels, original magnification ·4; right panels, original magnification ·20).A and B)A clearly visible blood
clot is noticeable at day 3. C and D) A significant number of RUNX2-positive cells are noticed within the alveolar socket populating the clot. E and F)
Remnants of the periodontal ligament can be clearly depicted by its strongPOSTN staining at day3. Gthrough L)At day 7, the cell density in the defect area
is higher and the POSTN- and RUNX2-positive cells start colocalizing within these areas. M through R) At day 10, the defect site seems to be filled by
a condensed mesenchymal tissue. S through X) Finally, by day14, an integration of the newly formed bone to the original socket walls is noticed.
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POSTN Protein Localization During Bone
Regeneration Around Implants
At 3 days, an inflammatory infiltrate seemed to dom-
inate most of the area within the peri-implant
defect and no POSTN signal was identified (Fig. 3).
However, by 7 days a loose fibrous tissue has repopu-
lated the peri-implant defect and distinct POSTN
signal is visualized within the immature extracellular
matrix. At 10 days a denser POSTN-positive con-
nective tissue is clear together with an increasingly
noticeable area of woven bone. Interestingly, at 14
days the mature trabecular structures are clearly
surrounded by osteoblasts with no POSTN immuno-
reactivity. However, the immediately adjacent matrix
and cellular population that localizes away from
the bone surface presents an intense and well-defined
signal.
RUNX2 Protein Localization During Tooth
Extraction Socket Healing
The immunohistologic localization of RUNX2 at day 3
clearly shows a robust presence of RUNX2-positive
cells within the granulation tissue that develops within
the alveolar socket (Fig. 2). By day 7 the RUNX2-ex-
pressing cells are localized mostly around and in close
proximity to the immature mineralizing structures. At
day 10 the positive immunoreactive cells are also lo-
calized within and aligned over the surface of the newly
formed trabeculae. A clear increase in bone surface
area characterizes the more mature alveolus and a cor-
responding saturation with RUNX2-positive cells.
RUNX2 Protein Localization During Bone
Regeneration Around Implants
Contrary to the tooth extraction model, RUNX2
was not localized at 3 days within the peri-implant
Figure 3.
Healing response for peri-implant repair sites at 3, 7, 10, and 14 days. A through D) Initially, inflammatory cells seem to dominate the defect area as
depictedat day 3. E through H) By day7, a loose fibrous connective tissue fills the defect and clear POSTN and RUNX2 staining is present. I throughL)At
day10, RUNX2-positive cells are abundant and POSTN is gradually limited to the more immature tissue areas. MthroughP) Similar to the tooth extraction
healing sites, at day 14, an integration of the newly formed bone to the walls of the defect is clear. Gray color in the top panels represents the implant location
area (top panels, original magnification ·4; second, third, and fourth panels and rows, original magnification ·20).
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defect (Fig. 3). It was initially observed at 7 days
within the loose connective tissue that was domi-
nating the defect area. At 10 days a significant in-
crease in signal and number of cells is clear and
localizes primarily over the woven bone surface.
At 14 days the matured structures are saturated
within and over the surface by RUNX2-expressing
cells.
DISCUSSION
The physiology and biology of skeletal and alveolar
bone are supported by a dynamic and complex
Figure 4.
Gene expression pattern of tooth extraction socket healing sites. ECM = extracellular matrix; TF = transcription factors. a = P <0.05 compared to day 3;
b = P <0.05 compared to day 7; c = P <0.05 compared to day 10; d = P <0.05 compared to day 14; e = P <0.01 compared to day 3; f = P <0.01 compared
to day 7; g = P <0.01 compared to day 10; h = P <0.01 compared to day 14.
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milieu that ultimately determines structural and func-
tional integrity.26-32 In each one of these systems,
multiple factors exert an effect (e.g., biochemical,
hormonal, cellular, biomechanical) and collectively
determine their quality.33-37 Clinically, bone quality
is perceived as an important feature that dictates
the mechanical properties of bone over time. Within
the skeleton, such characteristics vary from one area
to another and are determined among many things by
cellular density, connectivity, bone density, bone ar-
chitecture, and the proportions of organic and inor-
ganic matrix.34,38-41 These characteristics are the
result of the orchestration of growth factors (e.g.,
Bmps, Vegf, and Tgfb-1); matrix molecules (e.g.,
Figure 5.
Gene expression pattern of bone regenerative sites around implants. ECM = extracellular matrix; TF = transcription factors. a = P <0.05 compared to
day 3; b = P <0.05 compared to day 7; c = P <0.05 compared to day 10; d = P <0.05 compared to day 14; e = P <0.01 compared to day 3; f = P <0.01
compared to day 7; g = P <0.01 compared to day 10; h = P <0.01 compared to day 14.
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Opn, OCN, and POSTN); immunologic mediators and
cytokines (e.g., Il1-b, Cxcl-2, -5 and -12); and the ac-
tion of important transcription factors and intracellular
molecules overtime (e.g., Runx2, Lmp1, and Scx).
This physiologic balance is often disrupted abruptly
after an injury. Therefore, healing of an injured tissue
usually leads to the formation of a tissue that differs in
morphology or function from the original tissue. This
type of healing is called ‘‘repair.’’ Although, it may
contain similar environmental cues that lead the oste-
ogenic process, the spatial and temporal dynamics of
the molecules may lean toward a delayed or altered
healing.42-45 Tissue ‘‘regeneration,’’ however, is a term
used to describe a healing process that leads to
complete restoration of morphology and function.
Therefore, the success of bone regeneration and os-
seointegration is influenced by an understanding of
the basic biologic and physiologic principles of bone,
because it aids the surgeon in selecting appropriate
biologics to enhance alveolar bone homeostasis.46-48
Capturing the molecular dynamic events that occur
during healing both in a socket healing and implant
osseointegration process represents a first step to-
ward understanding the cooperative action of mul-
tiple factors including growth factors, extracellular
matrix molecules, and chemokines. Wound healing
therapeutic methods using growth factors to target
restoration of alveolar bone has advanced the field
of oral and periodontal regenerative medicine.49,50
A major focus of oral and craniofacial reconstruction
is on the impact of growth factor delivery strategies
using growth factor–producing cells, proteins, or genes
encoding growth factors.49 Advances in molecular
cloning have made available unlimited quantities
of recombinant growth factors for applications in tis-
sue engineering of the craniofacial complex includ-
ing alveolar bone. Within the alveolar socket and
peri-implant space several interactions between
cells and a diverse mixture of matrix proteins take
place.
We noted for both the bone repair model and the os-
seointegration models that three distinct expression
patterns were displayed (Figs. 4 and 5). The first
pattern is genes that are slowly increased during the
healing process, such as Bmp4, Runx2, and Ocn.
These genes are well-known to be critical in the early
stages of osteogenesis and bone regeneration.51 The
second pattern included genes that are upregulated at
the early stage of healing and then downregulated at
later stages, such as Il-1b, Cxcl2, and Cxcl5.52 These
molecules may indeed be of significant importance in
the host defense during the early stages of inflam-
mation and soft tissue wound repair. The final pattern
is genes that are constitutively expressed overtime,
such as Scx (e.g., Scx is a member of the basic-helix-
loop-helix superfamily of transcription factors).53 As
such, cells in the healing wound site may lead to the
eventual formation of tendon tissue, which may pro-
vide particular progenitors of connective and liga-
mentous tissues.
Within the scope of this study, we selected POSTN
and RUNX2 protein localization to show the events
that mediate both matrix stabilization and cell matu-
rity. In future studies, dynamics with respect to the
protein dynamics for other important matrix mole-
cules, growth factors, and transcription factors should
be explored. Particularly interesting is the exclusive
spatial expression of POSTN by remnants of the
PDL on the healing socket at 3 days. This distinct ex-
pression pattern contrasts with its absence within the
rapidly proliferative granulation tissue. Interestingly,
a significant number of RUNX2-positive cells seemed
to populate and dominate the clot and supportive con-
nective tissue. As the healing process evolves, both
POSTN and RUNX2 expression increases spatially
within the healing area as reflected at 7 days. By 10
days, the protein localization polarizes primarily to
the bone surface area in the case of RUNX2, and
POSTN is limited to areas that appeared less matured
but with intense signal. This pattern is maintained and
even more distinct as the tissue matures, as shown by
14 days.
Similarly to the tooth extraction model, the peri-im-
plant healing process mimics the dynamics of the
healing alveolus. However, the early events at 7 and
10 days are delayed and reflect a less mature healing
environment. POSTN distribution is clearly limited to
the preosteoblastic supportive connective tissue,
whereas RUNX2 is more intense within osteocytic
and osteoblastic cells.
Although bone tissue exhibits a large regeneration
potential and may restore its original structure and
function completely, bony defects may often fail to
heal properly. Identifying critical aspects that stabilize
the wound and mediate the osteogenic process could
help favor healing in osseous defects in challenging
clinical situations. These data together with the cur-
rent developments in cell, protein, and gene delivery
technology offer exciting potential therapeutic path-
ways to aid the clinician in the predictable repair of
bone defects to allow oral reconstructive therapies
for patient care.
CONCLUSIONS
Overall, the expression of osteogenesis-related growth
factors was gradually increased over time, whereas
chemokines tended to decrease. The expression of ex-
tracellular matrix proteins significantly increased at
later stages (days 10 and 14). There was an apparent
tissue maturation delayed during osseointegration, co-
mpared to the alveolar socket healing or what could
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be interpreted as an extended maturation phase.
Future investigations can hopefully extend on this
work to better understand the molecular mecha-
nisms of oral bone repair and osseointegration.
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